UW spinout TwinStrand has completed a $50m series B round led by Section 32, while Alexandria Venture Investments invested a third time.

TwinStrand Biosciences, a US-based genetic sequencing technology spinout of University of Washington, closed a $50m series B round yesterday led by Section 32. Alexandria Venture Investments, a vehicle for life sciences real estate investment trust Alexandria Real Estate Equities, also took part, as did Soleus Capital, Janus Henderson Investors, Madrona Venture Group, Ridgeback Capital and…

The rest of this content is only accessible to University Venturing: News, Data, and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.